Prognosis of Japanese breast cancer based on hormone receptor and HER2 expression determined by immunohistochemical staining

World Journal of Surgery

Volumn 32, Issue 11, 2008, Pages 2477-2482

  Nakajima, Hiroo ^a,b   Fujiwara, Ikuya ^a   Mizuta, Naruhiko ^a   Sakaguchi, Koichi ^a   Hachimine, Yasushi ^a   Konishi, Eiichi ^a   Yanagisawa, Akio ^a   Magae, Junji ^c  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Central Research Institute of Electric Power Industry ^*  (Japan)

^c CENTRAL RESEARCH INSTITUTE OF ELECTRIC POWER INDUSTRY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CAUCASIAN; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAPANESE; MAJOR CLINICAL STUDY; PROGNOSIS; PROTEIN EXPRESSION; RACE DIFFERENCE; RECURRENT DISEASE; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; JAPAN; MIDDLE AGED; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS; SURVIVAL RATE; YOUNG ADULT;

EID: 53949109605     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-008-9712-8     Document Type: Article

References (16)

1. CM Perou T Sorlie MB Eisen 2000 Molecular portraits of human breast tumors Nature 406 747 752
2. T Sorlie R Tibshirani J Parker 2003 Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci USA 100 8418 8423
3. C Sotiriou SY Neo LM McShane 2003 Breast cancer classification and prognosis based on gene expression profiles from a population-based study Proc Natl Acad Sci USA 100 10393 10398
4. J Jacquemier C Ginestier J Rougemont 2005 Protein expression profiling identifies subclasses of breast cancer and predicts prognosis Cancer Res 65 767 779
5. DM Abd El-Rehim SE Pinder CE Paish 2004 Expression of luminal and basal cytokeratins in human breast carcinoma J Pathol 203 661 671
6. LA Carey CM Perou CA Livasy 2006 Race, breast cancer subtypes, and survival in the Carolina breast cancer study JAMA 295 2492 2502
7. JD Brenton LA Carey AA Ahmed 2005 Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J Clin Oncol 23 7350 7360
8. M Dowsett J Bartlett IO Ellis 2003 Correlation between immunohistochemistry (Hercep Test) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centers J Pathol 199 419 423
9. A Goldhirsch JH Glick RD Gelber 2005 Meeting highlights: International expert consensus on the primary therapy of early breast cancer Ann Oncol 16 1569 1583
10. NCCN Clinical Practice Guidelines in Oncology Breast Cancer v.2. (2007) Available at http://www.nccn.org/professionals/physician_gls/PDF/breast.pdf (accessed October 31, 2007)
11. MJ Piccart-Gebhart M Procter B Leyland-Jones 2005 Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer N Engl J Med 353 1659 1672
12. EH Romond DF Perez J Bryant 2005 Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer N Engl J Med 353 1673 1684
13. R Rouzier CM Perou WF Symmans 2005 Breast cancer molecular subtypes respond differently to preoperative chemotherapy Clin Cancer Res 11 5678 5685
14. LA Carey EC Dees L Sawyer 2007 The triple negative paradox: primary tumor chemosensitivity of breast cancer Clin Cancer Res 13 2329 2334
15. HY Chang DS Nuyten JB Sneddon 2005 Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival Proc Natl Acad Sci USA 1025 3738 3743
16. K Sakaguchi H Nakajima N Mizuta 2005 Selective cytotoxicity of ascochlorin in ER-negative human breast cancer cell lines Biochem Biophys Res Commun 329 46 50